3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other neoplasm
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Menstruation Disturbances
1
Leiomyoma
1
Endometriosis
1
Endometrial Neoplasms
1
Adenomyosis
1
Interventions
Melphalan
3
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Taxes
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Paclitaxel
2
Mycophenolic Acid
2
Magnetic Resonance Spectroscopy
2
Educational Status
2
Cyclophosphamide
2
Busulfan
2
Aminolevulinic Acid
2
venetoclax
1
tirbanibulin
1
taxane
1
ruxolitinib
1
radium Ra 223 dichloride
1
X-Rays
1
Sirolimus
1
Robotic Surgical Procedures
1
Resistance Training
1
Platinum
1
Photons
1
Patient Reported Outcome Measures
1
Methotrexate
1
Methods
1
Mesna
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Robotic Surgical Procedures
×
Other neoplasm
×
90 days
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled